Nektar Therapeutics’s NKTR share price has surged by 18.21%, which has investors questioning if this is right time to sell.

BMS-986458 features three stereocenters, one of which epimerizes easily, Mortensen said. The drug candidate, which would be taken orally, is currently in Phase 1 clinical trials ( NCT06090539) alone ...

Once thought improbable, in vitro human models are demonstrating technological prowess in a growing range of applications.

Of these liposomal formulations, conventional liposomes (“naked” liposomes) and polyethylene glycol (PEG ... which efficiently drives a molecule of choice across the lipid membrane leading ...

Scenario 1As a rule of thumb, Esther Kinyua, a mother of two, buys medication from reputable pharmacies. According to Esther, she relies on certain visual and service-based cues to determine whether a ...

Due to hemophilia A patients switching to newer treatments, Takeda Pharmaceuticals is discontinuing both Hemofil M and Recombinate globally.

Significant progress has been made in the study of glycolipid metabolism disorders in cardiovascular and cerebrovascular diseases, due to rapid advancements in the fields of multi-omics, gene editing, ...

Therefore, pharmacists are not required to sell these chemicals. To summarize, methylene blue is a fascinating molecule with a long history and potentially diverse applications, from malaria ...

This useful study presents computational analyses of over 5,000 predicted extant and ancestral nitrogenase structures. While the data and some analyses are solid, the study remains incomplete in ...